Medicine

The Safety and Efficacy of Absnow Fully Biodegradable Atrial Septal Defect Occluder: A Prospective, Single‐Center Phase III Clinical Trial

S. Fan, Ying Xie, Zhenheng Ou, Piaohong Liang, Wei Wang, Meng Li, Cong Liu, Boning Li

2026.2.1CLINICAL CARDIOLOGY

DOI: 10.1002/clc.70262

Abstract

To evaluate the safety, short‐term and mid‐term occlusion performance of the Absnow fully biodegradable atrial septal occluder in pediatric patients.

Citation format

FAN, S., et al. The safety and efficacy of absnow fully biodegradable atrial septal defect occluder: A prospective, single‐center phase III clinical trial. CLINICAL CARDIOLOGY, 2026, 49(2): e70262.